IRIS UniCatt

Biolato, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.092
AS - Asia 2.510
EU - Europa 2.273
SA - Sud America 463
AF - Africa 59
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.408
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.015
SG - Singapore 1.147
DE - Germania 589
CN - Cina 571
BR - Brasile 397
SE - Svezia 390
IT - Italia 387
VN - Vietnam 250
FR - Francia 214
GB - Regno Unito 129
IE - Irlanda 124
UA - Ucraina 115
IN - India 89
FI - Finlandia 84
ID - Indonesia 83
JP - Giappone 75
RU - Federazione Russa 71
BD - Bangladesh 57
HK - Hong Kong 55
CA - Canada 44
TR - Turchia 39
PL - Polonia 29
AR - Argentina 27
BE - Belgio 26
KR - Corea 25
ZA - Sudafrica 24
IQ - Iraq 20
NL - Olanda 18
ES - Italia 14
SA - Arabia Saudita 14
AT - Austria 13
LT - Lituania 13
PK - Pakistan 12
MX - Messico 10
CZ - Repubblica Ceca 9
IR - Iran 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
CL - Cile 7
PE - Perù 7
PH - Filippine 7
RO - Romania 7
CI - Costa d'Avorio 6
DK - Danimarca 6
DZ - Algeria 6
EC - Ecuador 6
EG - Egitto 6
GR - Grecia 6
KE - Kenya 6
VE - Venezuela 6
AU - Australia 5
JM - Giamaica 5
PY - Paraguay 5
UZ - Uzbekistan 5
EU - Europa 4
JO - Giordania 4
KG - Kirghizistan 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
TH - Thailandia 4
AL - Albania 3
BO - Bolivia 3
CO - Colombia 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IL - Israele 3
LK - Sri Lanka 3
MD - Moldavia 3
PA - Panama 3
PT - Portogallo 3
TN - Tunisia 3
BY - Bielorussia 2
CG - Congo 2
CR - Costa Rica 2
CY - Cipro 2
HU - Ungheria 2
IS - Islanda 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
RE - Reunion 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 8.399
Salva come PNG Salva come JPEG
Città #
Singapore 630
San Jose 386
Ashburn 334
Chandler 322
New York 185
Dublin 124
Beijing 121
Dallas 97
Rome 94
Los Angeles 85
Ho Chi Minh City 84
Hefei 82
Lauterbourg 80
Milan 77
Jakarta 75
Tokyo 69
Jacksonville 64
Hanoi 57
Chicago 51
Frankfurt am Main 51
San Mateo 51
Nanjing 49
Munich 46
Wilmington 46
Helsinki 45
Boston 44
Cattolica 41
Hong Kong 41
São Paulo 39
Dearborn 35
Moscow 35
Santa Clara 35
The Dalles 35
Tukwila 34
Marseille 31
Princeton 28
Brussels 26
Seoul 25
Kent 24
Ann Arbor 22
Council Bluffs 22
London 21
Nürnberg 19
Woodbridge 19
Atlanta 17
Boardman 17
Buffalo 17
Nuremberg 17
Redwood City 17
Saint Petersburg 17
Turku 17
Augusta 16
Houston 16
Paris 16
Seattle 16
Izmir 15
Johannesburg 15
Montreal 15
Nanchang 15
Bremen 14
Tianjin 14
Denver 13
Falls Church 13
Orem 12
Palermo 12
Brooklyn 11
Changsha 11
Da Nang 11
Dhaka 11
Phoenix 11
Rio de Janeiro 11
Shanghai 11
St Louis 11
Toronto 11
Baghdad 10
Hebei 10
Kraków 10
Norwalk 10
Shenyang 10
Warsaw 10
Amsterdam 9
Bexley 9
Fairfield 9
Guangzhou 9
Haiphong 9
Istanbul 9
Poplar 9
Falkenstein 8
Guarulhos 8
Kunming 8
Lawrence 8
Brasília 7
Düsseldorf 7
Goiânia 7
Lancaster 7
Las Vegas 7
Mumbai 7
North Bergen 7
Stockholm 7
Washington 7
Totale 4.519
Salva come PNG Salva come JPEG
Nome #
A phase II study of sunitinib in advanced hepatocellular carcinoma 278
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 239
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 228
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 202
Liver transplantation in patients with alcoholic liver disease: A retrospective study 190
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 176
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 173
Vanishing-recurrent benign liver lesions 172
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 168
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 167
[The treatment of hepatocellular carcinoma: an update] 161
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 158
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 152
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 149
Severe giant cell arteritis associated with essential thrombocythaemia. 148
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 148
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 146
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 143
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 136
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 134
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 132
Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia 125
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 123
A giant calcified hepatic mass 122
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves 121
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 120
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 120
Acute HEV hepatitis: clinical and laboratory diagnosis 119
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 119
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 118
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 117
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 116
Clinical impact of comorbidities in an Italian NAFLD cohort 109
Starvation hepatitis and refeeding-induced hepatitis: mechanism, diagnosis, and treatment 108
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study 107
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 107
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma 105
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 103
Frequency of and reasons behind non-listing in adult patients referred for liver transplantation: Results from a retrospective study 103
Correlation of the transaminases alteration with the clinical severity of patients with COVID-19: A meta-analysis of the first global outbreak 98
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 98
A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series 98
Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 96
COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT 93
Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines 93
Liver stiffness in the early post-liver transplant phase as a marker of acute allograft rejection 92
Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI 92
ORGANIZATIONAL AND ECONOMIC ISSUES RELATED TO THE INTRODUCTION OF BOCEPREVIR IN THE TREATMENT OF PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN ITALY 90
Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy 90
Fatty liver and drugs: the two sides of the same coin 87
Prognostic ability of BCLC-B subclassification in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 87
ELF TEST IS A RELIABLE NON INVASIVE TEST FOR FIBROSIS IN NAFLD SUBJECTS 86
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach 86
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 82
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 81
Correction to: Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI (BMC Gastroenterology, (2021), 21, 1, (317), 10.1186/s12876-021-01878-3) 80
Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review 79
Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all 78
FREQUENCY OF AND REASONS BEHIND NON-LISTING IN ADULT PATIENTS REFERRED FOR LIVER TRANSPLANTATION 77
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 77
FREQUENCY AND REASONS FOR NON-LISTING IN REFERRED ADULT PATIENTS FOR LIVER TRANSPLANTATION 77
Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoholic fatty liver disease 76
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 76
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 76
Upper limits of downstaging for hepatocellular carcinoma in liver transplantation 75
Liver transplantation for drug-induced acute liver failure 74
Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? 73
Severe Cholestatic Hepatitis due to Temozolomide: An Adverse Drug Effect to Keep in Mind. Case Report and Review of Literature 61
HEPATOMA ARTERIAL-EMBOLISATION PROGNOSTIC SCORE PREDICTS PROGRESSION IN HEPATOCELLULAR CARCINOMA TREATED BY RADIOFREQUENCY ABLATION PLUS TRANSARTERIAL CHEMOEMBOLIZATION 60
FIBROSIS PROGRESSION DURING SUNITINIB THERAPY IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA 59
THE 15 AND 30 MINUTES SAMPLING OF 13C-BREATH TESTING ARE ABLE TO PREDICT SEVERE HEPATIC FIBROSIS AND SEVERITY OF LIVER DISEASE 58
Liver functional reserve and survival after sunitinib therapy in cirrhotic patients with advanced hepatocellular carcinoma 57
HEPARANASE IN NASH: IS IT AN USEFUL MARKER OF FIBROGENESIS? 55
Abdominal angina 51
GAPO syndrome: a comprehensive examination and review of 105 clinical cases 49
Corrigendum to "Acute hepatitis caused by a natural lipid-lowering product: When "alternative" medicine is no "alternative" at all" [J Hepatol 50 (2009) 1273-1277] (DOI:10.1016/j.jhep.2009.02.021) 33
Totale 8.512
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.163
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022406 14 23 9 49 36 16 15 69 14 17 65 79
2022/20231.070 132 110 55 144 93 157 63 94 103 33 69 17
2023/2024708 48 171 26 46 34 109 45 33 13 40 47 96
2024/20251.415 31 29 125 55 107 54 42 61 204 131 310 266
2025/20263.659 567 111 270 412 536 273 621 169 283 215 137 65
Totale 8.512